-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SihaaMe8LtLVBr9x/4Lwe2OrsBMdEVR84yfV4aHBR/dVvyVtF4B/HLFemyC5fqxn e/+eHP2JfM/MAZxxNN9eCQ== 0001096906-08-001703.txt : 20080903 0001096906-08-001703.hdr.sgml : 20080903 20080903145923 ACCESSION NUMBER: 0001096906-08-001703 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080903 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20080903 DATE AS OF CHANGE: 20080903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UTAH MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0000706698 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870342734 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12575 FILM NUMBER: 081053738 BUSINESS ADDRESS: STREET 1: 7043 S 300 WEST CITY: MIDVALE STATE: UT ZIP: 84047 BUSINESS PHONE: 8015661200 8-K 1 utahmedical8k090308.htm UTAH MEDICAL PRODUCTS, INC. FORM 8-K SEPTEMBER 3, 2008 utahmedical8k090308.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): September 3, 2008


Commission File No. 0-11178


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


UTAH
87-0342734
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)


7043 South 300 West
Midvale, Utah  84047
Address of principal executive offices


Registrant's telephone number:
(801) 566-1200
  

 
 
 
 
 
ITEM 7.01 Regulation FD Disclosure
 
 
Update of Projected Minimum Royalties Expected in 2009 and 2010

In UTMD’s SEC Form 10-K for the year ended December 31, 2007, the Company made the following statement regarding its expectations for receiving royalties in future years:

“As a matter of policy, UTMD licenses its proprietary technology to others in circumstances where licensing does not directly compete with UTMD's own marketing initiatives.  During 2007, the Company received $450 in royalty income, the same as in 2006 and 2005.  Based on the expiration dates of the patents for which the current royalty income is being received and the $450 annual maximum, UTMD expects royalties of at least $450, $450 and $310 in 2008, 2009 and 2010, respectively.  UTMD’s future financial performance also depends on the marketing ability of other companies that license UTMD’s technology.”

The projection for 2008 was accurate.  Based on a new interpretation of the expiration dates of patents for which current royalty income is being received, the Company does not expect to receive the minimum royalties in 2009 and 2010 as previously announced.


 
SIGNATURES

 
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
     
     
Date:         9/3/2008          
By:
      /s/ Kevin L. Cornwell
   
Kevin L. Cornwell
   
CEO
 

 
 -----END PRIVACY-ENHANCED MESSAGE-----